Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMRC0EQ)

Drug Name

Bertilimumab Drug Info

Synonyms

CAT-213; ICo-008

Indication

Disease Entry	ICD 11	Status	REF
Bullous pemphigoid	EB41.0	Phase 2	[1]
Ocular allergy	4A81	Phase 2	[2]
Psoriasis vulgaris	EA90	Phase 2	[3]
Ulcerative colitis	DD71	Phase 2	[3]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Small-inducible cytokine A11 (CCL11)	TTCF05Y	CCL11_HUMAN	Modulator	[4]

------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Emerging drugs for ocular allergy. Expert Opin Emerg Drugs. 2005 Aug;10(3):505-20.
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.